Welcome to our dedicated page for Alexandria Real Estate Eq news (Ticker: ARE), a resource for investors and traders seeking the latest updates and insights on Alexandria Real Estate Eq stock.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is an S&P 500 life science REIT that regularly issues detailed updates on its operations, leasing activity, capital allocation, and Megacampus™ developments. The news flow for Alexandria reflects its role as an owner, operator, and developer of Class A/A+ properties in major life science innovation clusters, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.
On this page, readers can follow company announcements about quarterly and year-end operating and financial results, including metrics such as funds from operations (FFO), net operating income, occupancy, leasing volume, and development pipeline progress. Alexandria frequently reports on large leases, such as long-term build-to-suit research hubs on its Campus Point and One Alexandria Square Megacampus ecosystems, as well as tenant collections, rental rate changes, and same property performance.
News items also cover Board decisions on quarterly cash dividends, explanations of dividend strategy in the context of liquidity and balance sheet strength, and authorizations or extensions of common stock repurchase programs. Investors can review how the company describes its capital recycling strategy, including dispositions of non-core assets, land sales, and partial interest sales intended to fund construction and manage leverage.
Beyond financial reporting, Alexandria’s releases highlight partnerships and recognitions within the broader life science ecosystem. Examples include strategic collaborations with large pharmaceutical companies on shared innovation hubs and awards from organizations such as the Foundation for the National Institutes of Health recognizing contributions to biomedical innovation. For ongoing context around ARE’s performance, strategy, and sector role, this news feed aggregates the company’s official press releases and related disclosures.
Alexandria Real Estate Equities (NYSE:ARE) reported mixed Q2 2025 results with a net loss of $(0.64) per share but maintained strong FFO of $2.33 per share. The company achieved significant leasing activity, including its largest-ever life science lease for 466,598 RSF with a multinational pharmaceutical tenant.
Key operational metrics include 90.8% occupancy (reaching 92.5% including leased but not delivered space), $762.0 million in quarterly revenues, and strong tenant collections at 99.9%. The company maintains a robust balance sheet with $4.6 billion in liquidity and a dividend yield of 7.3%.
ARE's 2025 capital recycling strategy progresses with $786 million in completed and pending dispositions, targeting $1.95 billion total for the year. Development projects delivered $15 million in incremental annual NOI during Q2, with an additional $139 million expected by Q4 2026.
Alexandria Real Estate Equities (NYSE:ARE) has won its first International TOBY Award in the Life Science category for its 8 Davis Drive property at the Alexandria Center for Advanced Technologies Megacampus in Research Triangle. The award, presented by BOMA, recognizes excellence in building management and operations.
The winning property is part of a 50-acre site acquired in 2012, which has been transformed into a multi-tenant ecosystem for R&D and biomanufacturing. The campus features amenities including a locally sourced eatery, fitness center, event space, and central courtyard. Alexandria is currently the largest owner and operator in Research Triangle Park, with a regional asset base exceeding 3.8 million RSF serving approximately 100 tenants.
Alexandria Real Estate Equities (NYSE:ARE) has secured its largest-ever life science lease, signing a 16-year agreement with a longtime multinational pharmaceutical tenant for a 466,598 RSF build-to-suit research hub at the Campus Point Megacampus in San Diego.
The Campus Point development currently comprises 1.3 million RSF in operation with 98.8% occupancy. The property has potential to expand to 2.6 million RSF, representing a 420% increase from initial acquisition. Construction of the new facility will begin in 2026 with expected completion in 2028. The project targets LEED Gold certification and 100% electrification.
Alexandria Real Estate Equities (NYSE:ARE), a pioneer in life science real estate, has released its 2024 Corporate Responsibility Report highlighting significant sustainability achievements. The company reported an 18% reduction in operational GHG emissions intensity from 2022 to 2024, progressing toward its 30% reduction target by 2030.
Key accomplishments include 54% of annual rental revenue from LEED-certified properties, winning the 2024 Nareit Sustainable Design Impact Award, and receiving the GRESB Green Star designation for the eighth consecutive year. The company also launched initiatives in mental health research and STEM education, including a partnership with the Foundation for the National Institutes of Health and a new learning lab at Fred Hutch Cancer Center.
Alexandria Real Estate Equities (NYSE: ARE) has scheduled its second quarter 2025 operating and financial results conference call and webcast for Tuesday, July 22, 2025, at 2:00 p.m. ET. The company will release its Q2 2025 results after market close on Monday, July 21, 2025.
Participants can join the call by dialing (833) 366-1125 (U.S.) or (412) 902-6738 and requesting to join the Alexandria Real Estate Equities call. A live webcast will be available on the company's investor website. A replay will be accessible from 4:00 p.m. ET on July 22 until July 29, 2025, via phone at (877) 344-7529 (U.S.) or (412) 317-0088 using access code 1006663.
Alexandria Real Estate Equities (NYSE: ARE) is intensifying its efforts to address the nation's mental health crisis through a multipronged approach. The company is leading a public-private partnership with the Foundation for the National Institutes of Health (FNIH) to develop biomarkers for depression treatment outcomes. Recent progress includes the FDA approval of Karuna Therapeutics' schizophrenia therapy and Intra-Cellular Therapies' potential new depression treatment.
Studies predict that by 2030, the global economic burden of mental health disorders will exceed that of cancer, diabetes, and respiratory diseases combined. ARE's initiatives include investing in innovative companies, advancing partnerships for biomarker development, influencing policy, and supporting organizations like the Navy SEAL Foundation, whose Warrior Fitness Program West Coast facility has helped over 200 active-duty warriors and veterans since late 2023.
Alexandria Real Estate Equities reported mixed Q1 2025 results with a net loss of $(0.07) per share, while maintaining strong operational metrics. The company posted total revenues of $758.2 million and Funds from Operations (FFO) of $2.30 per share.
Key highlights include:
- Strong occupancy at 91.7% for North American properties
- Robust leasing of 1.0 million RSF in Q1, marking the fifth consecutive quarter exceeding 1 million RSF
- Solid rental rate increases of 18.5% (7.5% cash basis) on renewals
- Healthy tenant base with 51% of rental revenue from investment-grade or large cap tenants
- Strong balance sheet with $5.3 billion in liquidity and 12.2 years weighted-average debt term
The company maintains a strategic dividend of $1.32 per share for Q1 2025, representing a 5.7% yield. Alexandria continues its capital recycling strategy with $176 million in completed dispositions and targets $1.95 billion in total 2025 dispositions.
Alexandria Real Estate Equities (NYSE: ARE) has been named one of the Most Trustworthy Companies in America by Newsweek for the third consecutive year. The recognition was based on a survey of 25,000 U.S. residents rating companies on customer, investor, and employee trust.
As the only publicly traded pure-play life science REIT, Alexandria maintains the largest laboratory infrastructure platform with approximately 750 tenants. The company's performance highlights include:
- 84% of leasing activity in 2024 from existing tenant relationships
- Average tenant retention rate of over 80% in the past five years
- 5.4% dividend yield with a 5.4% average annual increase since 2020
- 55% payout ratio for Q4 2024
- 4.0% average annual voluntary employee turnover rate (2020-2024)
The company recently supported the grand opening of the National Medal of Honor Museum in Arlington, Texas, on March 22, demonstrating its commitment to corporate responsibility.
FAQ
What is the current stock price of Alexandria Real Estate Eq (ARE)?
What is the market cap of Alexandria Real Estate Eq (ARE)?
